NeuPath Health Dividend

Dividend criteriumcontroles 0/6

NeuPath Health does not have a record of paying a dividend.

Belangrijke informatie

n/a

Dividendrendement

n/a

Terugkoop Rendement

Totaal aandeelhoudersrendement	n/a
Toekomstig dividendrendement	n/a
Dividendgroei	n/a
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	n/a
Uitbetalingsratio	n/a

Recente dividendupdates

Geen updates

Recent updates

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Aug 18

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Jun 16

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Apr 23

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Mar 01

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Dec 20

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Aug 19

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Insufficient data to determine if NPTH's dividends per share have been stable in the past.

Groeiend dividend: Insufficient data to determine if NPTH's dividend payments have been increasing.

Dividendrendement versus markt

NeuPath Health Dividendrendement versus markt

Hoe verhoudt NPTH dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (NPTH)	n/a
Markt onderkant 25% (CA)	1.8%
Markt Top 25% (CA)	6.1%
Gemiddelde industrie (Healthcare)	3.7%
Analist prognose (NPTH) (tot 3 jaar)	n/a

Opmerkelijk dividend: Unable to evaluate NPTH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hoog dividend: Unable to evaluate NPTH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Winstuitkering aan aandeelhouders

Verdiendekking: Insufficient data to calculate NPTH's payout ratio to determine if its dividend payments are covered by earnings.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Unable to calculate sustainability of dividends as NPTH has not reported any payouts.

NeuPath Health Dividend

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente dividendupdates

Recent updates

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Second quarter 2024 earnings released: EPS: CA$0.005 (vs CA$0.001 in 2Q 2023)

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

First quarter 2024 earnings released: CA$0.007 loss per share (vs CA$0.004 loss in 1Q 2023)

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

NeuPath Health Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.002 loss per share (vs CA$0.086 loss in FY 2022)

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Third quarter 2023 earnings released: EPS: CA$0.007 (vs CA$0.022 loss in 3Q 2022)

An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc. (TSXV:NPTH).

An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc. (TSXV:NPTH).

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Second quarter 2023 earnings released: EPS: CA$0.001 (vs CA$0.007 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.019 loss in 1Q 2022)

Full year 2022 earnings released: CA$0.086 loss per share (vs CA$0.072 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.022 loss per share (vs CA$0.014 loss in 3Q 2021)

High number of new and inexperienced directors

NeuPath Health Inc Announces Board Changes

NeuPath Health Inc. Announces Resignation of Dianne Carmichael as Director and Executive Chair

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.025 loss in 2Q 2021)

NeuPath Health Inc. Announces Grant Connelly Step Down from Chief Executive Officer, on or Before August 19, 2022

First quarter 2022 earnings released: CA$0.019 loss per share (vs CA$0.016 loss in 1Q 2021)

High number of new and inexperienced directors

NeuPath Health Inc., Annual General Meeting, Jun 22, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 3Q 2020)

NeuPath Health Inc. (TSXV:NPTH) completed the acquisition of KumoCare Inc.

Second quarter 2021 earnings released

CFO & Corporate Secretary Stephen Lemieux has left the company

NeuPath Health Inc. (TSXV:NPTH) agreed to acquire KumoCare Inc. for $1.1 million.

First quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.05 loss in 1Q 2020)

NeuPath Health Inc. Announces Revenue Guidance for the First Quarter of 2021

Full year 2020 earnings released

NeuPath Health Inc. (TSXV:NPTH) acquired Healthpointe Medical Centres Ltd. for CAD 6.7 million.

New 90-day low: CA$0.72

New 90-day low: CA$0.75

NeuPath Health Inc. has completed a Composite Units Offering in the amount of CAD 10.44 million.

New 90-day high: CA$1.10

Insider recently bought CA$60k worth of stock

First half earnings released

Stabiliteit en groei van betalingen

Dividendrendement versus markt

Winstuitkering aan aandeelhouders

Contante uitbetaling aan aandeelhouders

Ontdek bedrijven met een sterk dividend